Astria Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	96.28	59.82	175.53	20.53	86.51	24.93
Short-Term Investments	131.44	268.31	71	205.91	39	20
Cash & Short-Term Investments	227.72	328.13	246.53	226.44	125.51	44.93
Cash Growth	-33.86%	33.10%	8.87%	80.42%	179.34%	23.96%
Prepaid Expenses	8.58	6.51	4.41	1.25	1.45	1.4
Restricted Cash	-	-	-	-	0.12	-
Total Current Assets	253.55	334.64	250.94	227.69	127.08	46.33
Property, Plant & Equipment	4.25	5.11	0.36	0.95	0.39	0.97
Other Long-Term Assets	14.07	2.61	3.36	2	0.05	0.17
Total Assets	271.87	342.36	254.67	230.63	127.51	47.46
Accounts Payable	1.14	4.32	1.51	0.79	1.56	1.54
Accrued Expenses	16.48	13.43	9.71	7.69	3.28	4.2
Current Portion of Leases	1.4	1.38	0.33	0.58	0.37	0.65
Total Current Liabilities	23.52	19.13	11.55	9.06	5.2	6.39
Long-Term Leases	3.06	3.97	-	0.36	-	0.4
Other Long-Term Liabilities	12.04	-	-	-	-	-
Total Liabilities	38.61	23.1	11.55	9.42	5.2	6.79
Common Stock	0.06	0.06	0.04	0.03	0.01	0
Additional Paid-In Capital	911.01	898.51	728.29	632.51	481.71	301.56
Retained Earnings	-773.2	-674.79	-580.53	-507.64	-455.81	-260.9
Comprehensive Income & Other	0.06	0.16	-	-0.08	-	-
Total Common Equity	137.93	223.94	147.79	124.82	25.91	40.67
Shareholders' Equity	233.25	319.26	243.12	221.22	122.31	40.67
Total Liabilities & Equity	271.87	342.36	254.67	230.63	127.51	47.46
Total Debt	4.46	5.35	0.33	0.94	0.37	1.05
Net Cash (Debt)	223.26	322.78	246.2	225.5	125.14	43.88
Net Cash Growth	-34.07%	31.10%	9.18%	80.19%	185.17%	29.10%
Net Cash Per Share	3.85	5.75	8.17	15.42	14.02	14.35
Filing Date Shares Outstanding	57.08	56.43	54.9	27.99	13.02	3.9
Total Common Shares Outstanding	56.43	56.43	41.03	27.5	13.02	3.35
Working Capital	230.03	315.51	239.39	218.63	121.87	39.94
Book Value Per Share	2.44	3.97	3.60	4.54	1.99	12.15
Tangible Book Value	137.93	223.94	147.79	124.82	25.91	40.67
Tangible Book Value Per Share	2.44	3.97	3.60	4.54	1.99	12.15

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q